OraSure Q2 revenue record $80.2M (+39% YoY) but GAAP EPS ($0.26); InteliSwab sales surge 95% QoQ

ORASURE TECHNOLOGIES INC

2022-Q2 EPS reported -$0.54 revenue$147,938,000

GAAP net loss of $18.8M vs. $1.4M loss in Q2 2021; gross margin fell to 34.4% from 53.2%.
Non-GAAP gross margin improved 250 bps sequentially to 40.1%; non-GAAP EPS ($0.00).
Q3 revenue guidance $90-95M (67-76% YoY growth); expects positive cash flow by Q4 2022.
Appointed Ken McGrath as CFO effective Aug 8; three directors resign Nov 8; Mara Aspinall to become Board Chair.
InteliSwab capacity now ~1.6M tests/week, expected to nearly double by early 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.